Evaluation of Vamorolone CYP3A4 Induction on Midazolam (a Sensitive CYP 3A4 Substrate) Pharmacokinetics

NCT06689527 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Drug Interaction

Interventions

DRUG: Vamorolone
DRUG: Midazolam

Sponsor

Santhera Pharmaceuticals